6 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Terminated 6 |
Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma | Phase 4 | Terminated | Mayo Clinic | 4 | 2020-12-04 | 2023-06-22 |
| Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies immune-checkpoint inhibitors therapies - Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC | Phase 4 | Terminated | Institut Paoli-Calmettes | 40 | 2019-10-16 | 2026-01-22 |
| Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation Sandostatin - Neuroendocrine Tumors, Carcinoid Syndrome | Phase 4 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 10 | 2016-02-02 | 2019-10-25 |
| HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma High Dose Interleukin-2, Ipilimumab - Metastatic Melanoma | Phase 4 | Terminated | Clinigen, Inc. | 29 | 2013-05-01 | 2023-12-05 |
| Post-approval Study of NovoTTF-100A in Recurrent GBM Patients NovoTTF-100A - Recurrent Glioblastoma Multiforme | Phase 4 | Terminated | NovoCure Ltd. | 13 | 2012-12-01 | 2016-03-02 |
| HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma vemurafenib + HD IL-2 - Metastatic Melanoma | Phase 4 | Terminated | Clinigen, Inc. | 53 | 2012-08-01 | 2021-02-01 |
Melanoma (3) · Skin Neoplasms (2) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Drug Resistant Epilepsy (1) · Epilepsy (1) · Glioblastoma (1) · Glioma (1) · Neoplasm Metastasis (1) · Neuroendocrine Tumors (1) · Recurrence (1) · Serotonin Syndrome (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Nerve Tissue (6) · Neoplasms by Site (4) · Neuroendocrine Tumors (3) · Nevi and Melanomas (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Neuroepithelial (2) · Nervous System Diseases (2)
aldesleukin (2) · Anticonvulsants (1) · Interleukin-2 (1) · Interleukins (1) · Ipilimumab (1) · Octreotide (1) · Vemurafenib (1) · perampanel (1)
Clinigen, Inc. (2) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Institut Paoli-Calmettes (1) · Mayo Clinic (1) · NovoCure Ltd. (1)
United States (4) · France (1)
Herbert Engelhard, MD, PhD (1) · Ivan Borbath, Prof (1) · James Lowder, MD (1) · Renaud Sabatier, MD (1) · Sapna Patel, MD (1) · Tharak Rao, MD (1) · William Sharfman, MD (1) · William Tatum (1)
2018 (1)